期刊論文1. | 李素華(20120600)。醫藥發明之專利個案探討:以我國長青樹藥品專利為例。國立臺灣大學法學論叢,41(2),647-723。 延伸查詢![new window](/gs32/images/newin.png) |
2. | 黃慧嫺(20090200)。專利連結(Patent Linkage)--藥品研發與競爭之阻力或助力?:談藥品查驗登記程序與專利權利狀態連結之發展。科技法律透析,21(2),24-37。 延伸查詢![new window](/gs32/images/newin.png) |
3. | Grossman, Steven J.(1990)。Experimental Use or Fair Use as a Defense to Patent Infringement。IDEA,30,243。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
4. | Hantman, Rolland D.(1985)。Experimental Use as an Exception to Patent Infringement。Journal of the Patent and Trademark Office Society,67,617。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
5. | Eisenberg, Rebecca S.(1989)。Patents and the Progress of Science: Exclusive Rights and Experimental Use。The University of Chicago Law Review,56(3),1017-1086。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
6. | 王立達(20080100)。限制競爭之專利侵害和解:尋求合適分析架構。全國律師,12(1),51-62。 延伸查詢![new window](/gs32/images/newin.png) |
7. | Eisenberg, Rebecca S.(1987)。Proprietary Rights and the Norms of Science in Biotechnology Research。Yale Law Journal,97(2),177-231。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
8. | Mossinghoff, Gerald J.(1999)。Overview Of The Hatch-Waxman Act And Its Impact On The Drug Development Process。Food and Drug Law Journal,54(2),187-194。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
9. | Mueller, Janice M.(2001)。No "Dilettante Affair": Rethinking The Experimental Use Exception To Patent Infringement For Biomedical Research Tools。Washington Law Review,76(1),1-65。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
10. | Kieff, F. Scott(2001)。Property Rights and Property Rules for Commercializing Inventions。Minnesota Law Review,85,697-754。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
11. | Merrill, Richard A.(1996)。The Architecture of Government Regulation of Medical Products。Va. L. Rev.,82,1753+1761-1766。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
12. | Weiswasser, Elizabeth Stotland、Danzis, Scott D.(2003)。The Hatch-Waxman Act: History, Structure, and Legacy。Antitrust Law Journal,71(2),585-608。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
13. | 李素華、張哲倫(20131200)。專利審查品質與專利訴訟的實證考察--臺灣智慧財產法院成立五年的數據回顧。月旦裁判時報,24,94-112。 延伸查詢![new window](/gs32/images/newin.png) |
14. | Robinson, Laura J.(2003)。Analysis of Recent Proposals to Reconfigure Hatch-Waxman。Journal of Intellectual Property Law,11,47-52。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
15. | ENGELBERG, ALFRED B.(1999)。SPECIAL PATENT PROVISIONS FOR PHARMACEUTICALS: HAVE THEY OUTLIVED THEIR USEFULNESS? A POLITICAL, LEGISLATIVE AND LEGAL HISTORY OF U.S. LAW AND OBSERVATIONS FOR THE FUTURE。IDEA,39,389-428。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
16. | Flannery, Ellen、Hutt, Peter(1985)。Balancing Competition and Patent Protection in the Drug Industry: The Drug Price Competition and Patent Term Restoration Act of 1984。Food, Drug, Cosmetic Law Journal,40(3),269-309。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
17. | Behrendt, Kristin E.(2002)。The Hatch-Waxman Act: Balancing Competing Interests or Survival of the Fittest?。Food Drug L. J.,57,247-249。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
18. | Israelsen, Ned A.(1989)。Making, Using, and Selling Without Infringing: An Examination of 35 U.S.C. Section 271(e) and the Experimental Use Exception to Patent Infringement。AIPLA Q. J,16,457。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
19. | Michel, Suzanne T.(1992)。The Experimental Use Exception to Infringement Applied to Federally Funded Inventions。High Tech. L. J,7,369。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
20. | Grom, Taren(19991001)。GENERICS Best Years to Come。MED AD NEWS。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
21. | Solow, Robert Merton(1957)。Technical Change and the Aggregate Production Function。The Review of Economics and Statistics,39(3),312-320。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
22. | 黃慧嫺(20060600)。淺析美國藥品上市審查程序之專利連結機制及其實施對我國可能產生之影響。科技法律透析,18(6),2-7。 延伸查詢![new window](/gs32/images/newin.png) |
23. | 王立達、陳蔚奇(20101200)。學名藥上市審查之專利連結制度:從美國經驗檢證其存立基礎與制度設計。國立臺灣大學法學論叢,39(4),349-406。 延伸查詢![new window](/gs32/images/newin.png) |
24. | Karp, Jordan P.(1991)。Note: Experimental Use as Patent Infringement: The Impropriety of a Broad Exception。The Yale Law Journal,100,2169-2188。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |